TCON News and Press, TRACON Pharmaceuticals Inc. From 10/21/19

TRACON Pharmaceuticals ( TCON -8.6% ) has entered into a Common Stock Purchase Agreement of up to $15M with Aspire Capital Fund. More news on: TRACON Pharmaceuticals, Inc., Read more ...

SAN DIEGO, Oct. 21, 2019 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (Nasdaq:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, wet age-related macular degeneration through our license to Santen Pharma...

SAN DIEGO, Oct. 07, 2019 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (Nasdaq:TCON), announced today that William Kaelin Jr., M.D., a member of TRACON’s Scientific Advisory Board since 2011, and Professor of Medicine at Harvard Medical School and the Dana-Farber Cancer Institute, was a...

SAN DIEGO, Sept. 03, 2019 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (Nasdaq:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, wet age-related macular degeneration through our license to Santen Pharm...

SAN DIEGO, Aug. 29, 2019 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (Nasdaq:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, wet age-related macular degeneration through our license to Santen Pharma...

SAN DIEGO, Aug. 28, 2019 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (Nasdaq:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, wet age-related macular degeneration through our license to Santen Pharma...

Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday (you c...

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , iTunes...

TRACON Pharmaceuticals Inc. (TCON) Q2 2019 Earnings Conference Call August 7, 2019 4:30 p.m. ET Company Participants Charles Theuer - President and CEO Scott Brown - Director, Controller Conference Call Participants Swapnil Malekar - Jefferies Presentation Operator ...

Tracon (NASDAQ: TCON ): Q2 GAAP EPS of -$0.21 misses by $0.02 . More news on: TRACON Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...